The possible role of pharmacogenetics is also illustrated by the substantial differences in the CYP2D6 phenotypes frequencies between the 22 tamsulosin-associated ILD cases and the healthy volunteers. The gene discussed is CYP2D6; the disease is interstitial lung disease.